human | Q5 |
P735 | given name | Sandra | Q1474819 |
Sandra | Q1474819 | ||
P106 | occupation | researcher | Q1650915 |
P5008 | on focus list of Wikimedia project | WikiProject COVID-19 | Q87748614 |
P21 | sex or gender | female | Q6581072 |
Q40597341 | A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci |
Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
Q37109758 | A genome-wide association study of breast cancer in women of African ancestry |
Q30416161 | A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry |
Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
Q37205864 | APOBEC3 deletion polymorphism is associated with breast cancer risk among women of European ancestry |
Q34619821 | Associations of hormone-related factors with breast cancer risk according to hormone receptor status among white and African American women |
Q64921568 | Chronic antibiotic use during adulthood and weight change in the Sister Study. |
Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
Q46958735 | Correction: Evaluating Genome-Wide Association Study-Identified Breast Cancer Risk Variants in African-American Women. |
Q30432415 | Enhanced statistical tests for GWAS in admixed populations: assessment using African Americans from CARe and a Breast Cancer Consortium |
Q34022151 | Evaluating 17 breast cancer susceptibility loci in the Nashville breast health study |
Q34339783 | Evaluating genome-wide association study-identified breast cancer risk variants in African-American women |
Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
Q36742577 | Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers |
Q33589487 | Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes |
Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
Q37045108 | Genome-wide association study of age at menarche in African-American women |
Q28655044 | Genome-wide scan of 29,141 African Americans finds no evidence of directional selection since admixture |
Q37523423 | High use of complementary and alternative medicine among a large cohort of women with a family history of breast cancer: the Sister Study |
Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
Q28474694 | Identification of a functional genetic variant at 16q12.1 for breast cancer risk: results from the Asia Breast Cancer Consortium |
Q31036626 | Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry |
Q37679492 | Interactions of hormone replacement therapy, body weight, and bilateral oophorectomy in breast cancer risk |
Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
Q34428438 | Local breast cancer spatial patterning: a tool for community health resource allocation to address local disparities in breast cancer mortality |
Q30977635 | Methodological Considerations in Estimation of Phenotype Heritability Using Genome-Wide SNP Data, Illustrated by an Analysis of the Heritability of Height in a Large Sample of African Ancestry Adults |
Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
Q47143943 | PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1. |
Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
Q34870700 | Replication and functional genomic analyses of the breast cancer susceptibility locus at 6q25.1 generalize its importance in women of chinese, Japanese, and European ancestry |
Q94552258 | The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action |
Q47553137 | The Sister Study Cohort: Baseline Methods and Participant Characteristics |
Q30428393 | The landscape of recombination in African Americans |
Q34034263 | Use of nonsteroidal anti-inflammatory drugs and reduced breast cancer risk among overweight women |
Q42654606 | Validity of self-reported breast cancer characteristics in a nationwide cohort of women with a family history of breast cancer |
Search more.